Gesellschaftsrecht / M&A

Steuern

Arbeitsrecht und Vergütung für Führungskräfte

Immobilien

cibes_bw

Homburger News

Share-Image Teamplate Deals-and-Cases

Homburger advised Cibes Lift Group AB on its acquisition of Meier + Co. AG

On June 30, 2025, Cibes Lift Group successfully acquired Meier + Co. AG, the leading supplier of vertical platform lifts and stair lifts in Switzerland. Through the acquisition, Cibes expanded its direct sales presence to Switzerland, strengthening its position on the European market.
A distributor for Cibes Lift Group since 2007, Meier + Co. AG offers lift solutions to public, commercial and residential customers, providing a full range of customer services, including sales, installation, maintenance and 24/7 support. Founded in 1952, Meier + Co. AG is based in Niedergösgen and has approximately 30 employees.
The Homburger team was led by Dieter Gericke and included Daniel Häusermann, Kaiyan Yeo, and Adrian Schwarz (all Corporate / M&amp;A), Reto Heuberger and Philippe Weber (both Tax), Gregor Bühler and Hélène Bruderer (both Employment), as well as Stefan Gäumann and Dominique Burà (both Real Estate).

Kapitalmarkt

Finanzmarktrecht

BeOne Medicines_bw_640x140

Homburger advised BeOne Medicines Ltd. on its redomiciliation to Switzerland

On May 27, 2025, BeOne Medicines Ltd., a global oncology company, officially completed its redomiciliation from the Cayman Islands to Basel, Switzerland, following shareholder approval on April 28, 2025. The redomiciliation to Switzerland strengthens BeOne’s presence and deepens its roots in a global biopharmaceutical hub, further enabling its growth strategy of bringing innovative medicines to patients around the world.
BeOne Medicines Ltd.&#8217;s American Depositary Shares are listed on the Nasdaq Global Select Market, each representing 13 ordinary shares of BeOne Medicines Ltd., each having a par value of USD 0.0001 per share (the “Ordinary Shares”), the Ordinary Shares are listed on The Stock Exchange of Hong Kong Limited, and the Ordinary Shares traded in Renminbi are listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange.
The Homburger team was led by David Oser (Corporate / M&amp;A, Capital Markets) and included Bianca Nedwed and Kaiyan Yeo (both Corporate / M&amp;A, Capital Markets), Stefan Bindschedler and Benjamin Leisinger (Banking and Finance) as well as Stefan Oesterhelt and Juliette Buob (both Tax).

IP / IT

Windward Bio_we_640x140

Homburger and Windward Bio

On January 10, 2025, Windward Bio Group AG, a Swiss-based private, clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases, announced its launch with a USD 200 m series A financing from lead investors OrbiMed, Novo Holdings and Blue Owl Healthcare Opportunities, and co-investors SR One, Omega Funds, RTW Investments, Qiming Venture Partners, Quan Capital and Pivotal bioVenture Partners. Windward Bio has entered into an agreement to license WIN378, a potential best-in-class, long-acting monoclonal antibody targeting the ligand of thymic stromal lymphopoietin (TSLP), from Kelun-Biotech and Harbour BioMed for global rights, excepting China and select smaller markets in Asia.
Proceeds from the financing will be used to develop a phase 2-ready, long-acting anti-TSLP antibody with best-in-class potential in asthma and chronic obstructive pulmonary disease (COPD).
Homburger AG advises Windward Bio on its set-up and financing. The Homburger team comprises Andreas Müller, Margrit Marti, Oliver Kneubühl, Kaiyan Yeo, Eric Huber, Jonas Stähli, Rebecca Sigrist and Carolina Rodriguez (all Corporate / M&amp;A), Stefan Oesterhelt and Juliette Buob (both Tax) and Luca Dal Molin (IP / IT).

Kaiyan
Yeo

Zulassung

Homburger advised Cibes Lift Group AB on its acquisition of Meier + Co. AG

Homburger advised BeOne Medicines Ltd. on its redomiciliation to Switzerland

Homburger advises Windward Bio on its USD 200 m Series A Financing

Join the Team

Kaiyan Yeo

Karriere

Sprachen

Zulassung

Teams

KaiyanYeo

Zulassung

Homburger advised Cibes Lift Group AB on its acquisition of Meier + Co. AG

Homburger advised BeOne Medicines Ltd. on its redomiciliation to Switzerland

Homburger advises Windward Bio on its USD 200 m Series A Financing

Join the Team

Kaiyan Yeo

Karriere

Sprachen

Zulassung

Teams

Kaiyan
Yeo